Ardelyx, Inc. (ARDX)
3.74
+0.03
(+0.81%)
USD |
NASDAQ |
Sep 04, 10:31
Ardelyx Net Income (Annual) : -61.60M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -61.60M |
| December 31, 2024 | -39.14M |
| December 31, 2023 | -66.07M |
| December 31, 2022 | -67.21M |
| December 31, 2021 | -158.16M |
| December 31, 2020 | -94.31M |
| December 31, 2019 | -94.94M |
| Date | Value |
|---|---|
| December 31, 2018 | -91.30M |
| December 31, 2017 | -64.34M |
| December 31, 2016 | -112.39M |
| December 31, 2015 | -29.62M |
| December 31, 2014 | -3.214M |
| December 31, 2013 | -6.564M |
| December 31, 2012 | -9.785M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| REGENXBIO, Inc. | -193.88M |
| ACADIA Pharmaceuticals, Inc. | 391.00M |
| Alnylam Pharmaceuticals, Inc. | 313.75M |
| Anika Therapeutics, Inc. | -9.979M |
| Savara, Inc. | -118.84M |